UY26416A1 - Compuestos - Google Patents

Compuestos

Info

Publication number
UY26416A1
UY26416A1 UY26416A UY26416A UY26416A1 UY 26416 A1 UY26416 A1 UY 26416A1 UY 26416 A UY26416 A UY 26416A UY 26416 A UY26416 A UY 26416A UY 26416 A1 UY26416 A1 UY 26416A1
Authority
UY
Uruguay
Prior art keywords
compounds
naphthylmethyl
isopropyl
butyl
methyl
Prior art date
Application number
UY26416A
Other languages
English (en)
Inventor
Andrew Fallery
John Gerad Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of UY26416A1 publication Critical patent/UY26416A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Un compuesto de la fórmula (I): donde: R es isopropilo; n es O; R1 es naftilmetilo; R2 es t-butilo; y R3 es metilo; es útil en el tratamiento de trastornos mediados por s-CD23.
UY26416A 1999-10-27 2000-10-25 Compuestos UY26416A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9925470.8A GB9925470D0 (en) 1999-10-27 1999-10-27 Novel compounds

Publications (1)

Publication Number Publication Date
UY26416A1 true UY26416A1 (es) 2001-05-31

Family

ID=10863507

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26416A UY26416A1 (es) 1999-10-27 2000-10-25 Compuestos

Country Status (32)

Country Link
US (2) US6673965B1 (es)
EP (1) EP1224164B1 (es)
JP (1) JP3922431B2 (es)
KR (1) KR20020044578A (es)
CN (1) CN1182107C (es)
AR (1) AR026244A1 (es)
AT (1) ATE284382T1 (es)
AU (1) AU766072B2 (es)
BR (1) BR0015082A (es)
CA (1) CA2389319A1 (es)
CO (1) CO5261576A1 (es)
CZ (1) CZ20021424A3 (es)
DE (1) DE60016622T2 (es)
DK (1) DK1224164T3 (es)
ES (1) ES2233474T3 (es)
GB (1) GB9925470D0 (es)
GC (1) GC0000142A (es)
HK (1) HK1049146A1 (es)
HU (1) HUP0203270A3 (es)
IL (1) IL149364A0 (es)
MX (1) MXPA02004228A (es)
MY (1) MY133601A (es)
NO (1) NO20021965L (es)
NZ (1) NZ518566A (es)
PE (1) PE20010898A1 (es)
PL (1) PL356524A1 (es)
PT (1) PT1224164E (es)
SI (1) SI1224164T1 (es)
TW (1) TW561141B (es)
UY (1) UY26416A1 (es)
WO (1) WO2001030747A1 (es)
ZA (1) ZA200203255B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2334636A2 (en) 2008-09-19 2011-06-22 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
WO2011068853A2 (en) 2009-12-01 2011-06-09 Boston Medical Center Corporation TREATMENT OF IgE-MEDIATED DISEASE
WO2011073845A1 (en) 2009-12-16 2011-06-23 Pfizer Inc. N-linked hydroxamic acid derivatives useful as antibacterial agents
KR101593288B1 (ko) 2011-03-07 2016-02-11 화이자 인코포레이티드 항균제로서 유용한 플루오로-피리디논 유도체
EP2694488B1 (en) 2011-04-08 2014-11-12 Pfizer Inc Isoxazole derivatives useful as antibacterial agents
JP2014514299A (ja) 2011-04-08 2014-06-19 ファイザー・インク 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体
EP2525213A1 (en) * 2011-05-16 2012-11-21 Renishaw plc Spectroscopic apparatus and methods for determining components present in a sample

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513331D0 (en) 1995-06-30 1995-09-06 British Biotech Pharm Matrix metalloproteinase inhibitors
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
DK1224164T3 (da) 2005-03-29
NO20021965D0 (no) 2002-04-25
AR026244A1 (es) 2003-02-05
ES2233474T3 (es) 2005-06-16
JP2003512450A (ja) 2003-04-02
MXPA02004228A (es) 2002-10-17
PE20010898A1 (es) 2001-10-13
GB9925470D0 (en) 1999-12-29
CA2389319A1 (en) 2001-05-03
CZ20021424A3 (cs) 2002-09-11
EP1224164B1 (en) 2004-12-08
JP3922431B2 (ja) 2007-05-30
HUP0203270A2 (hu) 2003-02-28
KR20020044578A (ko) 2002-06-15
AU766072B2 (en) 2003-10-09
CN1411436A (zh) 2003-04-16
IL149364A0 (en) 2002-11-10
EP1224164A1 (en) 2002-07-24
SI1224164T1 (en) 2005-06-30
PL356524A1 (en) 2004-06-28
PT1224164E (pt) 2005-04-29
BR0015082A (pt) 2003-04-15
HUP0203270A3 (en) 2003-11-28
WO2001030747A1 (en) 2001-05-03
ATE284382T1 (de) 2004-12-15
CN1182107C (zh) 2004-12-29
NZ518566A (en) 2004-02-27
AU1389501A (en) 2001-05-08
HK1049146A1 (en) 2003-05-02
DE60016622T2 (de) 2005-11-03
US6673965B1 (en) 2004-01-06
GC0000142A (en) 2005-06-29
CO5261576A1 (es) 2003-03-31
US20040077727A1 (en) 2004-04-22
NO20021965L (no) 2002-06-13
ZA200203255B (en) 2003-03-20
TW561141B (en) 2003-11-11
MY133601A (en) 2007-11-30
DE60016622D1 (de) 2005-01-13

Similar Documents

Publication Publication Date Title
NZ514711A (en) Compounds useful as anti-inflammatory agents
ECSP055809A (es) Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4
NO20050065L (no) Kjemiske forbindelser
DE69925133D1 (de) Pyrrolobenzodiazepine
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
ATE487493T1 (de) Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen
ATE297203T1 (de) Antithrombotische mitteln
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE316962T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
DE60318826D1 (de) Alkoxypyridinderivate
ATE368645T1 (de) Aminosäurederivate als hiv-protease-inhibitoren
DE60112960D1 (de) Kondensierte pyridoindolderivate
UY26416A1 (es) Compuestos
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DE60128100D1 (de) Analgetisches arzneimittel
SE9903290D0 (sv) Novel compounds
ATE270273T1 (de) Substituierte azetidinone als entzüngdungshemmende und antidegenerative wirkstoffe
DE60005517D1 (de) Kaliumkanal-blockierende mittel
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
BR0206922A (pt) Compostos orgânicos
ATE419238T1 (de) Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz
SE0004827D0 (sv) Therapeutic compounds
AR027349A1 (es) Derivados de amidas heterociclicas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20120119